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Abstract
Background: Integrated Infectious Diseases Capacity Building Evaluation (IDCAP) teams designed and implemented
two health worker in-service training approaches: 1) an off-site classroom-based integrated management of
infectious diseases (IMID) course with distance learning aspects, and 2) on-site support (OSS), an educational
outreach intervention. We tested the effects of OSS on workload and 12 facility performance indicators for
emergency triage assessment and treatment, HIV testing, and malaria and pneumonia case management
among outpatients by two subgroups: 1) mid-level practitioners (MLP) who attended IMID training (IMID-MLP)
and 2) health workers who did not (No-IMID).
Methods: Thirty-six health facilities participated in the IDCAP trial, with 18 randomly assigned to Arm A and
18 to Arm B. Two MLP in both arms received IMID. All providers at Arm A facilities received nine monthly OSS visits
from April to December 2010 while Arm B did not. From November 2009 to December 2010, 777,667 outpatient visits
occurred. We analyzed 669,580 (86.1 %) outpatient visits, where provider cadre was reported. Treatment was provided
by 64 IMID-MLP and 1,515 No-IMID providers. The effect of OSS was measured by the difference in pre/post changes
across arms after controlling for covariates (adjusted ratio of relative risks = aRRR).
Results: The effect of OSS on patients-per-provider-per-day (workload) among IMID-MLP (aRRR = 1.21; p = 0.48) and
No-IMID (aRRR = 0.90; p = 0.44) was not statistically significant. Among IMID-MLP, OSS was effective for three indicators:
malaria cases receiving an appropriate antimalarial (aRRR = 1.26, 99 % CI = 1.02-1.56), patients with negative malaria test
result prescribed an antimalarial (aRRR = 0.49, 99 % CI = 0.26-0.92), and patients with acid-fast bacilli smear negative
result receiving empiric treatment for acute respiratory infection (aRRR = 2.04, 99 % CI = 1.06-3.94). Among No-IMID,
OSS was effective for two indicators: emergency and priority patients admitted, detained or referred (aRRR = 2.12,
99 % CI = 1.05-4.28) and emergency patients receiving at least one appropriate treatment (aRRR = 1.98, 99 % CI = 1.21-3.24).
Conclusion: Effects of OSS on workload were not statistically significant. Significant OSS effects on facility performance
across subgroups were heterogeneous. OSS supported MLP who diagnosed and treated patients to apply IMID
knowledge. For other providers, OSS supported team work to manage emergency patients. This evidence on OSS
effectiveness could inform interventions to improve health workers’ capacity to deliver better quality infectious diseases
care.
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Background
Sub Saharan Africa experiences 37 % of the total deaths
attributable to infectious diseases globally [1], but contains
only 3 % of the world’s health workers [2]. The shortage of
physicians in sub Saharan Africa is at critical levels, with
only 2 physicians per 10,000 population compared to 28
in high-income regions [3]. This shortage of physicians
has led to many physician roles, such as initiation of
antiretroviral therapy shifting to mid-level practitioners
(MLP) with fewer years of medical training [4], formally
[5–7] and informally [8, 9]. Yet as reported in one
Ugandan study, many of these MLP have not been trained
to take on these tasks [10]. They therefore require capacity
building to meet the demands of changing health policies
and guidelines [11]. Some studies have shown that with
additional training MLP can competently execute physi-
cians’ roles and, in some instances, match their per-
formance [12–14]. However, most trainings for MLP
are classroom-based, often taking them away from their
workstations [15, 16], disrupting workflows and limit-
ing patients’ access to care. Several systematic reviews
show that classroom-based training may not equip the
attendants with sufficient skills to ensure adherence to
clinical guidelines [17–19].
There is increasing interest from experts and donors
in favor of educational outreach and continuous quality
improvement (CQI) approaches [20–24] that integrate
across diseases [25–28]. Facility-based educational out-
reach trainings increase opportunities for team-based
interactions during MLP learning [20, 29] and reduces
MLP time away from health facilities. Several studies
have shown that educational outreach both with and
without CQI activities can improve the quality of patient
care [5, 30–35]. It may also build capacity in patient care
for almost all providers, without increasing workload on
the MLP who do not attend trainings.
Between 2009 and 2010, the curriculum development
and mobile teams of the Integrated Infectious Diseases
Capacity Building Evaluation (IDCAP) developed and
delivered two novel interventions to build capacity for
treatment and prevention of infectious diseases: 1) the
Integrated Management of Infectious Disease (IMID)
course with distance learning aspects, taught at the
Infectious Diseases Institute in Kampala, Uganda, and 2)
facility-based on-site support (OSS) visits, an educational
outreach intervention with CQI activities [29]. Imple-
mented as a mixed design with pre/post and cluster
randomized trial components, IDCAP tested the effect
of IMID training and OSS on individual clinician com-
petence [36], practice [37], mortality among children less
than five years of age [20, 38], and facility performance
[33, 39]. IMID was associated with a statistically signifi-
cant 9.8 % absolute increase in clinical competence,
whereas OSS was not associated with an incremental
improvement in the same outcomes. [36]. For clinical
practice, IMID was associated with statistically significant
improvements in taking a patient’s history and physical
examination, and OSS was associated with an incremental
improvement in these tasks [37]. Child mortality increased
in both arms, but the incremental effect of OSS delayed
the increase during the intervention [38].
In the main trial analysis of facility performance, [33]
Weaver et al. reported the effects of IDCAP’s IMID and
OSS on 23 facility performance indicators. Facility per-
formance refers to the process of care, and may reflect
the contributions of more than one provider at a facility.
For example, the proportion of malaria suspects with
a malaria test result recorded (Indicator 4), reflects
whether or not the clinician ordered the test, and the
laboratory professional performed the test and recorded
the result. Of the 23 indicators, 12 were based on a data
surveillance system with data on each outpatient visit. The
other 11 indicators were based on Ministry of Health
Registers for HIV care, maternal, child and newborn
health and tuberculosis. The 12 indicators based on the
data surveillance system are presented in Table 1, and
include three indicators for emergency triage assessment
and treatment, four indicators for malaria case manage-
ment, four indicators for case management of respiratory
illness, and one indicator for HIV testing.
Among those 12 indicators, Weaver et al.’s reported that
IMID alone was associated with statistically significant
pre/post improvements in three indicators: outpatients
triaged (Indicator 1), emergency and priority patients who
were admitted, detained or referred (Indicator 2), and
pneumonia suspects under age five assessed for pneumo-
nia (Indicator 8). A combination of IMID and OSS was
associated with statistically significant improvements in
four indicators: outpatients triaged (Indicator 1), emer-
gency and priority patients who were admitted, detained
or referred (Indicator 2), 3) estimated malaria cases who
received appropriate antimalarial treatment (Indicator 5),
and patients with a negative malaria test result who were
prescribed an antimalarial (Indicator 6), for which a
decrease was an improvement. The incremental effect of
OSS was not statistically significant for any of the 12
indicators, but many of the effect sizes were large.
We hypothesized that OSS improved facility perform-
ance more among the providers who attended IMID
training (IMID-MLP) compared to the ones who did not
(No-IMID). Weaver et al.’s analysis included all patients,
and we suspected that the No-IMID subgroup could
have diluted the effects of OSS in the IMID-MLP
subgroup. We therefore sought to test the effect of OSS
on the 12 indicators based on the data surveillance
system in the two subgroups of health providers: IMID-
MLP and No-IMID. The analysis was limited to only
outpatient visits with data to identify provider cadres,
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Table 1 Definitions of facility performance indicators
Program area and performance indicator Definition Reference
Emergency Triage, Assessment and Treatment (ETAT)
1 Proportion of outpatients triaged Numerator: Number of outpatients triaged, meaning that the patient was
classified as emergency, priority, or queue, or an emergency sign was noted
in the triage section of the form. Denominator: Number of outpatients
[50, 51]
2 Proportion of emergency and priority patients who
were admitted, detained or referred
Numerator: Number of emergency and priority patients admitted, detained
or referred for care. Denominator: Number of outpatients classified as
emergency or priority or an emergency sign was noted in the triage section
of the form.
In line with World Health Organization guidelines, emergencies were defined
as patients with one or more of the ABCDO triage signs (i.e., Airway;
Breathing difficulty; Circulation / Coma / Convulsion / Confusion;
Dehydration; and Other). Priorities were defined as patients with the
3TPR-MOB priority signs (i.e. Tiny baby (sick child of under 2 months of age);
Temperature (child is very hot); Trauma or other urgent surgical condition;
Pallor (severe); Poisoning; Pain (severe); Respiratory distress; Restless, lethargy
or continuously irritable; Referral; Malnutrition (severe wasting); Oedema of
both feet; and Burns) [52].
[50, 51]
3 Estimated proportion of emergency patients who
received at least one appropriate treatment
Numerator: Number of emergency patients who received at least one
treatment prescribed according to ETAT standards where the standards were
reported in Kinoti et al. (manuscript under review in PlosOne). For emergency
patients who were prescribed treatment and data on drug availability were
missing, we applied the “in-stock” rate for patients with those data.
Denominator: Number of outpatients classified as emergency or an emergency
sign was noted in the triage section of the form
[50, 51]
Case management of fever and malaria
4 Proportion of malaria suspects with a malaria test
result recorded
Numerator: Number of malaria suspects with a result for a laboratory test or
rapid diagnostic test for malaria, where the definition of a malaria suspect
was reported in Mbonye et al. [37]. Denominator: Number of malaria suspects
[16, 39, 53]
5 Estimated proportion of malaria cases who received
an appropriate antimalarial
Numerator: Number of outpatients treated with appropriate anti-malarial(s),
where appropriate antimalarial treatments were quinine and four artemisinin-
based combination therapies reported in Mbonye et al. [37]. For patients
who were prescribed an antimalarial and data on drug availability were
missing, we applied the “in-stock” rate for patients with those data.
Denominator: Number of outpatients treated for malaria
[16, 39, 53]
6 Proportion of patients with a negative malaria test
result who were prescribed an antimalarial
Numerator: Number of patients with a negative malaria test result prescribed
any antimalarial including appropriate treatments and those that do not
comply with Ugandan national guidelines. Denominator: Number of patients
with a negative malaria test result
[16, 39, 53]
7 Proportion of patients with a positive malaria test
result who were prescribed an antibiotic
Numerator: Number of patients with a positive malaria test result prescribed
any antibiotic(s), where antibiotic treatment refers to the 31 drugs listed in
Mbonye et al. [37]. Denominator: Number of patients with a positive malaria
test result
[16, 39, 53]
Case management of respiratory illness
8 Proportion of pneumonia suspects aged under
5 years assessed for pneumonia
Numerator: Number of child pneumonia suspects with at least one of the
three following assessment results recorded: 1) abnormal chest sounds,
2) chest in-drawing, and 3) rapid breaths per minute. A pneumonia suspect
was defined as any child aged under five years presenting with cough or
who received a diagnosis of “pneumonia” or “cough/cold no pneumonia”.
Denominator: Number of child pneumonia suspects. Note: The definition of
suspect focused on children with cough; difficulty in breathing was
inadvertently omitted from the form.
[54]
9 Estimated proportion of patients aged under
5 years diagnosed with pneumonia who received
appropriate antibiotic treatment
Numerator: Number of children diagnosed with pneumonia treated with
appropriate antibiotic, where appropriate antibiotic treatment referred to
six drugs on the revised Medical Form 5: amoxicillin, benzyl penicillin,
erythromycin, chloramphenicol, gentamicin, cotrimoxazole, and 11 other
drugs that were specified: ampicillin, azithromycin, cefixime, ceftriaxone,
cefuroxime, co-amoxiclav, gatifloxacin, levofloxacin, penicillin, phenoxymethyl
penicillin, ampiclox (amoxicillin and cloxacillin). For patients who were
prescribed an antibiotic and data on drug availability were missing, we
applied the “in-stock” rate for patients with those data. Denominator: Number
of children diagnosed with pneumonia
[54]
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and whether or not the provider attended IMID training.
In this article, the term “indicator” refers to the facility
performance indicators.
Also, during the ethical review of the IDCAP protocol,
the School of Medicine Ethics and Research Committee
of Makerere University expressed concern that the inter-
ventions would affect the distribution of the workload.
The data surveillance system data provided an oppor-
tunity to examine whether workload increased among
the IMID-MLP with OSS, and among the No-IMID
health workers with OSS. We therefore tested the effect




We conducted a secondary analysis of IDCAP data. As
noted above, IDCAP was a mixed design study consisting
of pre/post and cluster randomized trial components. It
was implemented at 36 health center IVs (HCIV) or com-
parable health facilities across Uganda. Eighteen of the 36
health facilities were randomized to Arm A and the other
18 to Arm B. In both arms, two MLP from each of the 36
health facilities received IMID training. From April to
December 2010, all providers at Arm A facilities received
nine monthly OSS visits while Arm B did not. The pre/
post component measured the effects of the combination
of IMID training and OSS in Arm A, and IMID training
alone in Arm B. The cluster randomized trial component
measured the incremental effect of OSS as the difference
between the pre/post effects in the two arms. Figure 1a
presents the design of the main test of facility performance
indicators, which is reported as the overall result below.
Note that the overall results presented in Table 5 differ
from the results of Weaver et al.’s analysis, because only
outpatient records with data on provider cadre and
whether or not the provider attended IMID training were
analyzed. Figure 1b presents the design of the subgroup
analysis.
The process of randomization, blinding, sample size
calculation, and recruitment for the cluster-randomized
trial were previously reported in Weaver et al. [33]. A
The IDCAP protocol is summarized by Naikoba et al.
[20]. The full protocol can also be accessed as supplemen-
tary file in both Mbonye et al. [39], Weaver et al. [33] and
is available as supporting information to this paper in
Protocol 1. The CONSORT checklist for this subgroup
analysis is available as Additional file 1.
Sites, participants, and inclusion criteria
The 36 study health facilities included 31 health center
IV (HCIV) and five small hospitals comparable in size to
HCIV. A HCIV serves a population of about 100,000
people providing basic preventive and curative care, and
is at the highest referral point for a health sub-district
[40]. Two MLP, defined as clinical officers, registered
Table 1 Definitions of facility performance indicators (Continued)
10 Proportion of TB suspects with a first Acid-Fast
Bacilli (AFB) smear result
Numerator: Number of TB suspects who get a first AFB smear result, where
TB suspect was defined as anyone with a history of: cough for longer than
two weeks, cough for less than two weeks and night sweats, cough for less
than two weeks and weight loss, TB test ordered, new TB diagnosis, started
on initial TB treatment, or referred for TB treatment. For children, the
definition extended to anyone who had contact with someone with TB.
Denominator: Number of TB suspects. Note: The definition of TB suspect is
from the Intensified Case Finding Form for People Living with HIV, contacts
of smear positive patients, and HIV care settings [55]. Increasing AFB smears
among TB suspects will increase case detection, but this is not the case
detection indicator used by the Stop TB program [56].
[52, 56–58]
11 Estimated proportion of patients with AFB smear
negative results who received empiric treatment
for acute respiratory infection
Numerator: Number of people with AFB smear negative test results who
received empiric treatment for acute respiratory infection, including
amoxicillin, doxycycline, or erythromycin. For patients who were prescribed
an antibiotic and data on drug availability were missing, we applied the
“in-stock” rate for patients with those data. Denominator: Number of people
with AFB smear negative result
[52, 56–58]
HIV testing and prevention
16 Proportion of patients with an HIV test result
recorded
Numerator: Number of outpatients who were not TB suspects with an HIV
test result recorded. TB suspect is defined for Indicator 10. Denominator:
Number of outpatients who were not TB suspects. Note: This indicator
included anyone who said they knew their HIV status in the protocol, and
was revised to comply with the MOH definition based strictly on a
laboratory test result on the day of the outpatient visit.
[58]
Numerator: Number of TB suspects with an HIV test result recorded. TB
suspect is defined for Indicator 10. Denominator: Number of TB suspects.
Note: This indicator included anyone who said they knew their HIV status in
the protocol, and was revised as described above.
Abbreviations: AFB Acid-fast bacilli, CQI Continuous Quality Improvement, HIV Human Immunodeficiency Syndrome, MOH Ministry or Health
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nurses or midwives, from each health facility participated
in the IMID training. Inclusion criteria for facilities and
IMID participants have been described elsewhere [20, 29].
Briefly, the key inclusion criteria for selecting IMID partic-
ipants was involvement in daily management of patients
in the outpatient clinics, and spending over 80 % of the
time seeing patients at the participating health facilities
[20]. All health workers including IMID participants were
invited to participate in the OSS sessions. All outpatients
participated as part of the routine healthcare seeking
process. For the subgroup analyses, as noted above, only
records of outpatient visits with data on the health pro-
vider’s cadre and whether or not the health provider
attended IMID training were included.
Interventions
IMID was a three-week core course followed by two
one-week booster courses at 12 and 24 weeks after the
core course and distance learning [29]. The core course
was taught in four sessions at the Infectious Diseases
Fig. 1 a Design of the overall comparison across arms. OSS refers to On-Site Support, IMID to Integrated Management of Infectious Disease, and
MLP to mid-level practitioners. b Design of the across arm comparisons within the IMID-MLP and No-IMID subgroups
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Institute in Kampala, Uganda with two sessions for Arm
A in March and April 2010 and two sessions for Arm B
in May and June 2010.
OSS was a two-day visit to the health facilities in Arm
A delivered by mobile teams for nine consecutive months
from April to December 2010 [20, 29]. Each mobile team
consisted of four members: a medical officer with CQI
experience, a clinical officer, a laboratory technologist, and
a registered nurse. Each visit focused on one OSS topic as
well as follow-up from the previous sessions and was
characterized by four distinct activities: the multidisciplin-
ary team training, one-on-one mentorship, breakout ses-
sions, and CQI activities.
Outcomes
The outcomes were patients per provider used to meas-
ure changes in workload, and 12 facility performance
indicators based on the data surveillance system whose
definitions by numerator and denominator are reported
in Table 1, as well as sources of the indicators. Indicator
16, proportion of patients with an HIV test recorded,
differs from the earlier report [33], because it excludes
registry data from antenatal and tuberculosis clinics.
Data collection
The data source was the revised Uganda Ministry of
Health outpatient medical form (MF5) [41]. Using the
MF5, health workers prospectively collected data on
every outpatient visit from November 2009 to December
2010. From March 2010, data entry assistants were
stationed at each health facility to capture these data
electronically in an Epi Info® Version 3.2 (U.S. Centers
for Disease Control and Prevention, Atlanta, GA) data-
base. At the end of each month, the data entry assistants
transmitted electronic data to the Infectious Diseases
Institute where data for all health facilities were merged
using Microsoft Excel® 2010 (Microsoft Corporation,
Redmond, WA, USA), and further cleaned.
Data analysis
We used frequencies to describe provider, patients, and
outcomes across arms, subgroups, and time periods. The
effect of OSS was estimated as a difference in pre/post
(Time 0/Time 1) changes between Arm A and Arm B.
In Arm A, Time 0 was from November 2009 to March
2010 and Time 1 started after the first IMID training in
Arm A and was from April to December 2010. In Arm
B, Time 0 was from November 2009 to May 2010 and
Time 1 started after the first IMID training in Arm B
and was from June to December 2010. During Time 1,
nine OSS visits were implemented in Arm A.
Using a generalized linear latent and mixed model
[42], data on the number of patients per provider were
analyzed as continuous dependent variables with main
effects for arm, subgroup, time period and their inter-
action to estimate pre/post differences within each
subgroup in each arm and ratios of relative risk (RRR)
for the effect of OSS within each subgroup. The unit of
analysis was a subgroup-facility-month, and regressions
were estimated with clusters for provider and facility
with robust standard errors.
The RRR for a given performance indicator was esti-
mated with main effects for arm, time period and their
interaction, using data for the total sample and for each
subgroup and the generalized linear model with a Poisson
family and log link as described earlier [33, 39]. The unit
of analysis was facility month, and all regression analyses
were clustered on the health facility. To adjust for over
dispersion and using Poisson rather than binomial family,
the regressions were estimated with robust standard
errors. Multiple comparisons were addressed by basing
the statistical tests on α = 0.01 and all results were pre-
sented with 99 % confidence intervals (CI).
All regression analyses were adjusted for facility type
(public or private not-for-profit), facility level (HCIV or
small hospital), data entry assistant on-site, Baylor and
previous participation in the national HIV CQI program
(see description of strata in [33, 39]). Indicators 1–7 and
10–11 were also adjusted for staffing and patient age
(<5, > = 5 years), indicators 8–9 for staffing, and indicator
16 for staffing, TB suspect and patient age group (2–14
months, 18 months – 13 years and ≥14 years) to reflect
HIV testing guidelines. All data analyses were conducted
using Stata® version 12 (StataCorp, College Station, Texas,
USA).
Ethical considerations
The School of Medicine Research and Ethics Committee
of Makerere University Kampala (reference number
2009–175) and the Uganda National Council for Science
and Technology (reference number HS-722) approved
the IDCAP protocol. The University of Washington
Human Subjects Division determined that IDCAP did
not meet the regulatory definition of research under 45
CFR 46.102 (d). This subgroup analysis was exempt




The flow of the participating health facilities, and IMID
training and OSS participants is presented in Fig. 2 [33].
All health facilities participated up to the end of the
study. Of the 36 individuals who participated in IMID
training, one person in Arm A and two in Arm B did
not attend one or more boost courses. Attendance of
OSS sessions was also not consistent. Out of 513 clinical
staff expected to attend multi-disciplinary team sessions,
Mbonye et al. BMC Public Health  (2016) 16:714 Page 6 of 14
only 440 (86 %) attended at least once; out of 499
clinical staff expected to attend the breakout session,
only 344 (69 %) attended at least once; and out of
351 clinical staff expected to attend the clinical men-
toring and coaching session, only 186 (53 %) attended
at least once. Among those who attended at least one
OSS session, the mean number of sessions attended
per clinical staff was 4.93 for multi-disciplinary team
sessions, 3.64 for breakout sessions and 4.01 for clin-
ical mentoring and coaching sessions.
A total of 777,667 outpatients visited the 36 health fa-
cilities during the study period. Of these visits, 669,580
(86.1 %) had data on the provider’s name and cadre,
which allowed us to determine whether or not the pro-
vider attended IMID training, and were included in this
analysis (Table 2). During these visits, patients were
seen by 64 IMID-MLP and 1,515 No-IMID providers.
Data on 108,087 (13.9 %) visits with missing (91,006),
unknown (14,686) or indeterminate (2,395) data on the
provider were omitted from the analysis.
Baseline
Patient volume
In Table 3, baseline data for the number of providers,
the number of patients seen, and the estimated number
of patients per provider per calendar day is reported by
time period, arm and subgroup. The number of patients
per provider per calendar day was higher in Arm B with
more hospitals than in Arm A in the IMID-MLP subgroup
(4.3 vs. 3.7) and similar across arms in the No-IMID sub-
group (1.1 vs. 1.1).
Patient care
In Table 4, baseline data for each indicator are reported
by both arm and subgroup. Performance in Arm B was
generally higher than in Arm A within both IMID-MLP
and No-IMID subgroups for eight out of the 12 indica-
tors. For indicators 6 (Proportion of patients with a
negative malaria test result who were prescribed an anti-
malarial), and 7 (Proportion of patients with a positive
malaria test result who were prescribed an antibiotic) a
Fig. 2 Consort flow diagram – recruitment and randomization
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lower percentage indicated better performance, and Arm
A had lower percentages than Arm B for both indicators.
Performance was highest for indicator 5 (estimated
proportion of malaria cases who received an appropriate
antimalarial). For the remaining indicators, performance
was generally low, did not exceed 64 % in both arms and
subgroups, and was as low as 3.1 % for indicator 8
(Proportion of pneumonia suspects aged under 5 years




As shown in Table 3, pre/post change in the number of
patients per provider per month from Time 0 to Time 1
among the IMID-MLP subgroup was higher in the Arm
A (adjusted relative risk (aRR) = 1.15, 99 % CI = 0.72-
1.85, p = 0.437) than in Arm B (aRR = 0.96, 99 % CI =
0.57-1.62, p = 0.828), and the effect of OSS in this
subgroup was not statistically significant (adjusted RRR
(aRRR) = 1.21; 99 % CI = 0.61-2.38, p = 0.478). In the No-
Table 3 Before and during OSS comparison of average number of patients per provider per month by subgroup and arm
Variable IMID-MLP No-IMID
Arm A Arm B Arm A Arm B
Part 1: Patient and provider population
Time 0
Total number of patients 19,686 25,708 59,614 126,611
Number of providers 35 28 358 559
Number of calendar days 151 212 151 212
Time 1
Total number of patients 54,904 26,163 174,935 181,956
Number of providers 36 26 496 641
Number of calendar days 275 214 275 214
Part II: Patients per provider per calendar day
Time 0 3.7 4.3 1.1 1.1
Time 1 5.5 4.7 1.3 1.4
Change (Time 1-Time 0) 1.82 0.37 0.15 0.28
Difference between Arm A and Arm B 1.45 −0.13
Part III: Regression aRR (99 % CI), p-value aRR (99 % CI), p-value aRR (99 % CI), p-value aRR (99 % CI), p-value
Time 1 – Time 0 1.15 (0.72, 1.85), 0.437 0.96 (0.57, 1.62), 0.828 0.99 (0.76, 1.30), 0.921 1.10 (0.88, 1.37), 0.264
aRRR (99 % CI), p-value aRRR (99 % CI), p-value
Effect of OSS in each group 1.21 (0.61, 2.38), 0.478 0.90 (0.63, 1.28), 0.443
**Denotes that the effect of OSS was significant at the .01 level and *Denotes that the effect of OSS was significant at the .05 level
The 99% confidence intervals (CI) are based on the .01 level of significance
Abbreviations: aRR adjusted relative risk, aRRR adjusted ratio of relative risks, IMID Integrated Management of Infectious Disease, OSS On-site support, MLP Mid-
level practitioners, RR Relative Risk measured the comparisons in pre/post change from Time 0 to Time 1; RRR Ratio of Relative Risk Measured the effect of OSS in
each subgroup
Estimates were adjusted for: whether the facility received the on-site intervention from Baylor International Pediatric AIDS Initiative or not, facility was implement-
ing continuous quality improvement prior to IDCAP trial, level of health facility (small hospital or health center IV), facility ownership (public or private-not-for
profit) and data entry assistant on-site
Table 2 Distribution of providers by arm and subgroup
Provider Arm A Arm B Total Patients
IMID-MLP No-IMID IMID-MLP No-IMID IMID-MLP No-IMID Total (Percent)
1 Medical Officer 0 64 0 80 0 144 32,994 (4.9)
2 Clinical Officer 24 137 19 193 44 330 370,745 (55.4)
3 Nurse 12 172 8 231 20 403 162,542 (24.3)
4 Midwife 0 0 1 0 1 0 51 (0.008)
5 Nursing Assistant 0 110 0 179 0 289 62,968 (9.4)
6 Other less skilled 0 163 0 186 0 349 40,280 (6.2)
Total 36 646 28 869 64 1,515 669,580
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IMID subgroup however, pre/post change was lower in
Arm A (aRR = 0.99, 99 % CI = 0.76-1.30, p = 0.922) than
Arm B (aRR = 0.1.10, 99 % CI = 0.88-1.37, p = 0.264), and
the effect of OSS was also not statistically significant
(aRR = 0.90; 99 % CI = 0.63-1.28, p = 0.443).
Facility performance
The effect of OSS on 12 facility performance indicators
is reported in Table 5. Overall, the incremental effect of
OSS was statistically significant for three indicators;
increases in the estimated proportion of emergency
patients who received at least one appropriate treatment
(Indicator 3, aRRR = 2.00; 99 % CI = 1.11-3.79, p = 0.003),
and estimated proportion of malaria cases who received
an appropriate antimalarial (Indicator 5, aRRR = 1.15,
99 % CI = 1.01-1.32, p = 0.006), and decrease in pro-
portion of patients with a negative malaria test result
prescribed an antimalarial (Indicator 6, aRRR = 0.65,
99 % CI = 0.44-0.98, p = 0.006). Within the IMID-MLP,
the incremental effect of OSS was statistically significant
for three indicators; increases in estimated proportion of
malaria cases who received an appropriate antimalarial
(Indicator 5, aRRR = 1.26, 99 % CI = 1.02-1.56, p = 0.005)
and estimated proportion of patients with acid-fast bacilli
(AFB) smear negative results who received empiric treat-
ment for acute respiratory infection (indicator 11, aRRR =
2.04, 99 % CI = 1.06-3.94, p = 0.005) and decrease in
proportion of patients with a negative malaria test result
prescribed an antimalarial (Indicator 6, aRRR = 0.49, 99 %
CI = 0.26-0.92, p = 0.004). Within the No-IMID subgroup,
the incremental effect of OSS was statistically significant
for only two indicators; increases in the proportion of
emergency and priority patients admitted, detained or
referred (Indicator 2, aRRR = 2.12, 99 % CI = 1.05-4.28,
p = 0.006), and estimated proportion of emergency pa-
tients who received at least one appropriate treatment
(Indicator 3, aRRR = 1.98, 99 % CI = 1.21-3.24, p < 0.001).
Compared to the No-IMID subgroup, the effect sizes were
larger in the IMID-MLP subgroup in seven (3, 5, 6, 8, 10,
11 and 16) of the 12 indicators measured.
Discussion
There have been limited rigorous randomized education
trials that demonstrate the effects of health worker
Table 4 Frequencies and percentages by arm, time period and subgroup
Ind
no.
Indicator Arm A Arm B
Time 0 Time 1 Time 0 Time 1
No-
IMID
IMID-MLP No-IMID IMID-MLP No-IMID IMID-MLP No-IMID IMID-MLP
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training approaches on patient care outcomes in the re-
source constrained world. In this study, we have evalu-
ated the effect of an educational outreach intervention
involving nine monthly on-site support (OSS) sessions
on health facility performance in two groups of trainees
– those who were provided with five weeks of off-site
classroom education and those who did not have this
opportunity.
The OSS intervention did not significantly increase
patient load within the subgroup of health providers
who did not participate in the IMID training. Among
the mid-level practitioners (MLP) who received both
IMID training and OSS, the number of patients per
provider per calendar day increased; but the changes in
workload attributable to OSS were not statistically sig-
nificant. The effects of OSS on facility performance
indicators were heterogeneous. Patients treated by health
providers who attended the IMID training benefited
from improved case management of malaria and respira-
tory infections. Patients treated by providers without the
IMID training benefited from improvements in emer-
gency triage, assessment and treatment.
The number of patients per provider per calendar day
was much lower than we expected. On average, the
health providers with IMID training saw 4.64 patients
per calendar day, and the other providers 0.83 indicating
that the MLP saw 5 times more patients than other pro-
viders. This was expected since MLP involved in daily
management of patients in the outpatient clinics and
spent over 80 % of their time at the health facility seeing
patients were prioritized during the selection process
[20]. These results for the MLP with IMID training are
consistent with those of the Institute for Health Metrics
and Evaluation’s report that showed health providers saw
an average of three to five patients per day [43]. These
results also indicate that health workers in Uganda treat
very few patients per day, but this finding contrasts with
other reports in which complaints of heavy workload have
been cited among health workers in Uganda [44] and
other sub-Saharan Africa countries [45, 46]. The reported
Table 5 Effect of OSS training on facility performance in each of the IMID-MLP and No-IMID groups
Ind
no.
Indicator Overall (n = 669,580) No-IMID (n = 543,119) IMID-MLP (n = 126,461)
aRRR (99 % CI) p-value aRRR (99 % CI) p-value aRRR (99 % CI) p-value
1 Proportion of outpatients triaged *1.67 (0.88, 3.16) 0.04 *1.68 (0.90, 3.16) 0.03 1.65 (0.63, 4.31) 0.18
2 Proportion of emergency and priority patients who were
admitted, detained or referred
*2.00 (0.93, 4.27) 0.02 **2.12 (1.05, 4.28) 0.006 1.31 (0.63, 2.72) 0.34
3 Estimated proportion of emergency patients who
received at least one appropriate treatment
**2.00 (1.11, 3.79) 0.003 **1.98 (1.21, 3.24) 0.000 *2.15 (0.83, 5.54) 0.04
4 Proportion of malaria suspects with a malaria test result
recorded
1.21 (0.86, 1.69) 0.15 1.21 (0.81, 1.82) 0.22 1.21 (0.80, 1.81) 0.24
5 Estimated proportion of malaria cases who received an
appropriate antimalarial
**1.15 (1.01, 1.32) 0.006 *1.12 (0.99, 1.27) 0.011 **1.26 (1.02, 1.56) 0.005
6 Proportion of patients with a negative malaria test result
who were prescribed an antimalarial
**0.65 (0.44, 0.98) 0.006 0.75 (0.48, 1.18) 0.10 **0.49 (0.26, 0.92) 0.004
7 Proportion of patients with a positive malaria test result
who were prescribed an antibiotic
0.94 (0.78, 1.13) 0.37 0.92 (0.77, 1.09) 0.20 1.13 (0.66, 1.96) 0.55
8 Proportion of pneumonia suspects aged under 5 years
assessed for pneumonia
1.05 (0.35, 3.15) 0.90 0.94 (0.32, 2.78) 0.89 1.21 (0.37, 4.03) 0.68
9 Estimated proportion of patients aged under 5 years
diagnosed with pneumonia who received appropriate
antibiotic treatment
0.95 (0.57, 1.58) 0.80 0.96 (0.59, 1.15) 0.83 0.95 (0.54, 1.69) 0.84
10 Proportion of TB suspects with a first Acid-Fast Bacilli
(AFB) smear result
1.03 (0.45, 2.38) 0.92 0.94 (0.39, 2.28) 0.88 1.19 (0.44, 3.17) 0.66
11 Estimated proportion of patients with AFB smear
negative results who received empiric treatment for
acute respiratory infection
*1.76 (0.93, 3.32) 0.023 1.58 (0.82, 3.03) 0.07 **2.04 (1.06, 3.94) 0.005
16 Proportion of patients with an HIV test result recorded
(all patients ≥2 months)
1.20 (0.73, 1.96) 0.35 1.10 (0.64, 1.87) 0.66 1.48 (0.84, 2.61) 0.07
**Denotes that the effect of OSS was significant at the .01 level and *Denotes that the effect of OSS was significant at the .05 level
The 99% confidence intervals (CI) are based on the .01 level of significance
Abbreviations: aRRR adjusted ratio of relative risk, IMID Integrated Management of Infectious Disease, OSS On-site support, MLP Mid-level practitioners, AFB Acid-
fast bacilli, HIV HumanImmunodeficiency Syndrome, TB Tuberculosis
aRRR adjusted Ratio of Relative Risk measured the effect of OSS in each subgroup
Estimates were adjusted for: whether the facility received the on-site intervention from Baylor International Pediatric AIDS Initiative or not, facility was implement-
ing continuous quality improvement prior to IDCAP trial, level of health facility (small hospital or health center IV), facility ownership (public or private-not-for
profit) and data entry assistant on-site
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number of patients seen per provider is an average across
the estimated working days for each of the study time
periods. It is possible that providers did not work on all
estimated days and thus treated a higher number of
patients on days when they worked [47]. In a review of
studies in six countries including Uganda, it was found
that 35 % of the health care providers were absent during
their assigned shifts [48]. Among many factors, the ab-
sence usually arises because health workers are on leave,
attending trainings off-site, tending to their gardens, or
doing work in private clinics to supplement their income
[47]. If health workers are only on duty an average of 65 %
of the time, then the average number of patients per pro-
vider per day would increase by one-third. It is also pos-
sible that the number of patients’ visits per day was higher
on some days than others. Adding in the fluctuations in
patient visits and it possible that some clinicians would
manage much higher number of patients on some days.
Further analysis is required to determine how the number
of patients per day seen by clinicians varies by day and
across facilities.
Among the health workers without the IMID training,
this analysis showed no statistically significant effect of
OSS on changes in the volume of patients they managed.
In fact, the number of patients seen per provider per
calendar day among these health providers remained the
same before and during the OSS. Yet a slight increase in
volume of patients seen per provider per calendar day
among the MLP with IMID training was observed dur-
ing OSS, although this increase was not statistically
significant. This increase in patient load among IMID
trainees coupled with no increase among providers who
did not attend IMID training, shows a general increase
in patient volume overall during OSS, perhaps pointing
to an appreciation of better quality services being offered
at the health facilities. Rather than shift tasks and work-
load among cadres, OSS sought to improve facility per-
formance within each cadre’s scope of practice. This
could explain why there was no significant increase in
patient volume among health workers without IMID
training and decrease among health workers without the
IMID training.
Overall, OSS was effective for three of the 12 facility
performance indicators in this subgroup analysis, com-
pared to none in the main IDCAP trial results [33]. In
this subgroup analysis, only records with complete data
on the provider’s cadre and IMID attendance were
analyzed unlike in Weaver et al.’s [33] analysis that
included all patient records. It is plausible that providers
with incomplete data also attended fewer OSS or bene-
fited less from them and diluted the effects. We saw
evidence of the no-IMID subgroup diluting the OSS
effects of the MLP with IMID especially for indicators
11 (patients with AFB smear negative results who
received empiric treatment for acute respiratory infec-
tion) and 16 (patients with an HIV test result recorded).
On the other hand, evidence of the MLP with IMID di-
luting the effects of the no-IMID subgroup was observed
for indicator 2 (emergency and priority patients who
were admitted, detained or referred).
The effects of OSS among the MLP with IMID tended
to be statistically significant for indicators that reflected
clinical decision-making, such as prescribing antimalarials
and antibiotics. In contrast, the effects of OSS among the
no-IMID subgroup were for emergency, triage and assess-
ment indicators that required a broader team effort to
identify and manage patients appropriately. Although
OSS did not seek to change a cadre’s scope of practice,
it did seek to empower all providers to triage patients
and organize immediate care for emergency and prior-
ity patients.
The effects of OSS observed in this analysis were
heterogeneous across indicators as well as across sub-
groups. In the overall sample, the average effect size was
34 % and higher than estimates elsewhere. For instance,
reviews of continuous medical education and effect of
educational outreach visits on health workers’ training
reported median improvements ranging from 6.9 to
13.9 % [19] and from 5.6 to 21 % [49] respectively.
The effect sizes for the emergency, triage and assess-
ment and malaria case management indicators were
generally larger than the effect sizes for case manage-
ment of respiratory infections and HIV testing. The
indicators for the first two coincide with the first two
OSS. The OSS sessions for the latter two were delivered
later in the intervention, an indication that perhaps, the
expectation of immediate improvements over a shorter
period of time may have been unrealistic. There is need
for monitoring these indicators over more months to ob-
serve whether facility performance will improve over time.
Also future researchers should consider designing their
trials for a subgroup analysis. Within resource-limited set-
tings in many sub-Saharan African countries, clinicians
and other higher level cadres are the ones usually selected
to attend continuous medical education trainings to sup-
port them improve the quality of diagnosis and treatment.
Allied health workers, nurses and other lower level pro-
viders often miss out on such opportunities since they
mainly play supporting roles to clinicians in providing
patient care. OSS would therefore be a great opportunity
to improve capacity of these non-clinician health workers
to dispense better quality patient care in the entire patient
care process. For clinicians and higher level cadres, OSS
would be important in supporting them to apply know-
ledge and skills in diagnosis and treatment acquired from
classroom training.
To our knowledge, the IDCAP trial is one of the first
randomized trials that evaluated the effects of an
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integrated educational outreach and quality improve-
ment intervention in sub-Saharan Africa. The results of
this study therefore provide important evidence that
could inform capacity building interventions and policies
for health workers in resource limited settings.
Limitations
As noted in Weaver et al. [33] sample size calculations
for the IDCAP trial were based on comparison across
arms and an α = 0.05. Consequently, this subgroup ana-
lysis may have been underpowered to detect difference-
in-difference at α = 0.01 when comparing effect of OSS
on facility performance between arms. OSS sessions
were delivered gradually for nine months, and its effect
may have been underestimated by measuring it during
its implementation rather than after.
Generalizability
This study was conducted in a sample of sub-district
level referral HCIVs or comparable small hospitals that
met the inclusion criteria. These results can thus be
generalized for similar health facilities in Uganda and
other countries, and for indicators for which OSS was
effective.
Conclusions
The MLP with IMID training managed thrice as many
patients per day compared to other providers. Out of the
12 facility performance indicators, OSS improved three
indicators across all patients and among patients managed
by MLP with IMID training, but only two indicators
among patients managed by providers without IMID
training. These results show that OSS supported MLP
who diagnosed and treated patients to apply knowledge
from IMID. For other providers, OSS supported team
work to manage emergency patients. Since provision of
patient care is a team effort with clear roles for every
health worker, health workers engaged in clinical diagnosis
and treatment may need OSS in addition to classroom
training, while the nurses and other providers who play a
supporting role to the clinicians will need OSS to effect-
ively contribute more to patient care.
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